<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0041">
 <label>41</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ismail</surname>
    <given-names>RS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abou-Seri</surname>
    <given-names>SM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Eldehna</surname>
    <given-names>WM</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2018</year>;
  <volume>155</volume>:
  <fpage>782</fpage>–
  <lpage>96</lpage>.
  <pub-id pub-id-type="pmid">30047410</pub-id>
 </mixed-citation>
</ref>
